Search for: "Bartlett v. State" Results 321 - 340 of 525
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Mar 2013, 6:58 am by Bexis
Bartlett – that is to say Mutual Pharmacy Co. v. [read post]
19 Mar 2013, 6:01 am by Joe Consumer
  In Wyeth v Levine, the Court pointed out that “Congress did not intend FDA oversight to be the exclusive means of ensuring drug safety and effectiveness’ and that state law serves as a ‘complementary form of drug regulation. [read post]
15 Mar 2013, 4:41 am by Rachel Sachs
Bartlett, in which the Court will consider whether federal law preempts state law design-defect claims brought against generic pharmaceutical products, here, and in Sebelius v. [read post]
12 Mar 2013, 6:47 am by Sarah Erickson-Muschko
Bartlett, scheduled for oral argument on March 19, in which the Court will consider whether federal law preempts a state-law design defect claim against a generic drug manufacturer. [read post]
11 Mar 2013, 9:05 am by Stephen Wermiel
United States (2012),  to decisions about the safety of medical devices, Riegel v. [read post]
5 Mar 2013, 6:29 am by Sarah Erickson-Muschko
At The Volokh Conspiracy, Dale Carpenter discusses the amicus brief he filed in United States v. [read post]
1 Mar 2013, 2:30 pm by Bexis
  And drug companies are deep pockets, so these cases provide one instance after another (Bartlett was another SJS/TENS case) of courts leaning over backwards to justify liability. [read post]
1 Feb 2013, 9:42 am by Bexis
The plaintiff in Arters asserted a “design defect”/“remove from the market” claim à la Bartlett v. [read post]
31 Jan 2013, 6:24 am by Cormac Early
Perry, the challenge to California’s Proposition 8, while Scottie Thomaston of Equality on Trial covers the National Organization for Marriage’s brief in United States v. [read post]
25 Jan 2013, 12:47 pm by Bexis
  We’ve received the same bone-headed response from an appellate court in a branded case, seeWimbush v. [read post]
17 Jan 2013, 8:07 am by WSLL
Justice Voigt respectfully dissented.Case Name: EDWARD VENARD v. [read post]
7 Jan 2013, 9:02 am by Lyle Denniston
Bartlett – must a maker of a generic drug that allegedly caused harm to a patent take the drug off the market if that is the only way it can obey both federal drug law and state drug product law Wednesday, March 20: 12-123 — Horne v. [read post]